Air Treatment

UV / UVGI Disinfection Device Testing

Bioaerosol, surface, and airflow testing for UV and ultraviolet germicidal irradiation devices.

ARE Labs evaluates UVGI performance under defined room, duct, chamber, surface, airflow, exposure, and sampling conditions.

ISO 17025ASHRAE 241ASHRAE 185.1 / ASHRAE 185.2ASTM E2315 / ASTM E3135Reviewed 2026-05-17
Request a quoteSubmit a sample

Testing UV / UVGI disinfection devices

UV / UVGI disinfection device testing measures how lamp output, wavelength, exposure geometry, airflow, residence time, organism susceptibility, surface material, and device state affect microbial reduction. ASHRAE 241, ASHRAE 185.1, ASHRAE 185.2, ASTM E3135, ASTM E2315, and ISO 17025 quality records provide the framework for room, duct, surface, and CFD-supported studies used in development, claim support, and documentation when:

  1. Room or upper-room UVGI devices need ASHRAE 241 and ASHRAE 185.1 aligned chamber data with organism recovery and device-off decay controls.
  2. Duct UVGI modules require ASHRAE 185.2 aligned upstream/downstream bioaerosol sampling tied to airflow, residence time, lamp state, and geometry.
  3. Surface-facing UV features need ASTM E3135 or ASTM E2315 aligned time-kill data across exposure time, distance, material, and organism.
  4. EPA or FIFRA claim files need truthful, configuration-specific reduction evidence, with limits stated for device setup, organism, and tested conditions.
  5. CFD-supported placement or sampling reviews use ASHRAE context to evaluate airflow, mixing, residence time, shadowing, and exposure zones.

UVGI testing is appropriate when microbial reduction depends on setup details that cannot be determined from lamp rating alone. Before testing begins, the study plan defines the exposure geometry, airflow, organism or surrogate, controls, dose records, and reporting limits.

UVGI device test menu

UVGI programs may combine airborne efficacy, surface time-kill, inline reduction, and airflow modeling. The study design depends on the claim language, installation geometry, and whether the device treats rooms, ducts, chambers, or exposed surfaces.

Test method options

MethodStrengthsTradeoffAligned with
Room or upper-room UVGI bioaerosol study
  • ASHRAE 241 aligned chamber studies quantify airborne organism reduction with device-off decay controls.
  • ASHRAE 185.1 context links UVGI exposure, airflow, mixing, and recovery to room or upper-room claims.
Room-scale results depend on chamber mixing, fixture placement, organism recovery, and exposure control.
ASHRAE 241ASHRAE 185.1 / ASHRAE 185.2ISO 17025
In-duct UVGI single-pass reduction study
  • ASHRAE 185.2 aligned duct testing measures upstream/downstream reduction at defined flow and residence time.
  • ISO 17025 records tie lamp state, airflow, sampling position, controls, and calculations together.
Duct geometry, bypass, lamp aging, and sampling losses must be controlled before reductions are compared.
ASHRAE 185.1 / ASHRAE 185.2ISO 17025
Surface UV exposure time-kill program
  • ASTM E3135 and ASTM E2315 frames support timed UV exposure across coupons, materials, and organisms.
  • Neutralization and recovery controls separate true inactivation from poor surface recovery or carryover.
Shadowed, curved, or textured surfaces may need custom fixtures before exposure time is meaningful.
ASTM E2315 / ASTM E3135ISO 17025
CFD-supported airflow and exposure review
  • ASHRAE context helps evaluate mixing, residence time, short-circuiting, and sampling location sensitivity.
  • Measured chamber or duct data can anchor CFD assumptions for placement and design comparisons.
CFD supports setup and interpretation; it does not replace measured microbial efficacy data.
ASHRAE 241ISO 17025
Claim-support and scope-limits package
  • EPA FIFRA framing helps connect tested configuration, organism, exposure, and reduction result to claim language.
  • CDC/NIOSH GUV guidance can inform occupied-room placement and exposure-control caveats.
This evidence does not provide electrical safety, ozone, radiation safety, or product certification.
EPA FIFRACDC/NIOSH GUV

Setup configurations

Each UVGI study begins with the device form, lamp state, airflow path, exposure geometry, and intended claim. The same product may require a room chamber, duct fixture, surface-coupon setup, or CFD model. Study planning defines the conditions below before challenge generation, surface inoculation, or modeling begins.

Device interfaces

Upper-room fixtures, duct inserts, chamber units, coupon holders, enclosures, shields, sampling ports, and lamp positions matched to the tested configuration.

Flow & actuation profiles

Fan speed, duct flow, residence time, warmup, duty cycle, lamp setting, operating mode, and device-on interval documented per condition.

Exposure profile

Wavelength or lamp type, irradiance, distance, angle, exposure time, surface material, shadowing risk, organism, and inoculum or aerosol load defined by protocol.

Environmental controls

Temperature, RH, airflow, mixing, chamber or duct background, lamp aging, fouling, and conditioning state recorded when they affect reduction.

Sample numbers

Replicate runs, device-off baselines, blanks, untreated controls, positive controls, and recovery checks sized to the claim and expected variability.

Quality frame for UVGI testing

UVGI studies distinguish the accredited laboratory quality anchor from the aligned air, duct, and surface method frameworks. Each item below corresponds to the accreditation row shown in the page hero.

  • ISO 17025AccreditedLaboratory competence, calibration traceability, method records, and data review.
  • ASHRAE 241AlignedInfectious aerosol control and equivalent clean airflow context.
  • ASHRAE 185.1 / ASHRAE 185.2AlignedUV-C air and duct device test context for microbial inactivation.
  • ASTM E2315 / ASTM E3135AlignedTime-kill and UVGI carrier context for surface exposure studies.

Key data outputs & reporting

UVGI device reports tie the tested configuration to measured airborne or surface microbial reduction. Depending on the study, outputs may include concentration decay, log reduction, percent reduction, upstream/downstream results, time-kill curves, exposure records, airflow conditions, CFD maps, controls, deviations, and limits on claim interpretation. Extended programs that compare lamp states, placements, organisms, surfaces, or device modes include side-by-side comparison artifacts.

Primary outputs

  • Airborne concentration versus time for device-on and device-off room or chamber runs, with background decay correction.
  • Upstream/downstream microbial concentration, single-pass reduction, airflow, residence time, lamp state, and duct geometry records.
  • Surface or coupon log reduction over exposure time, with recovery controls, neutralization evidence, and material notes.
  • CFD velocity, residence-time, mixing, shadowing, and sampling-location outputs when modeling is included.

Deliverables

#FormatContents
01PDF reportMethods, setup, controls, results, deviations, QA/QC, and interpretation limits.
02CSV / XLSX datasetsConcentrations, reductions, exposure records, recovery checks, and replicate tables.
03FiguresDecay curves, log-reduction plots, inlet/outlet comparisons, and CFD visuals.
Extended deliverables · multi-arm comparability · stability · predicate studies
  • Configuration comparison pack — Side-by-side results across lamp state, airflow, placement, exposure distance, surface material, or operating mode.
  • Claim-support table — Mapping from each tested claim to organism, setup, endpoint, control set, result, and stated limitation.
  • Modeling appendix — CFD assumptions, boundary conditions, sensitivity findings, and validation comparisons against measured data.

QA / QC & data integrity

UVGI studies use controls to distinguish device inactivation from background decay, sampler behavior, poor recovery, lamp drift, and environmental variation. Under ARE Labs' ISO 17025 quality system, records are maintained from sample receipt through final review, with traceability for devices, organisms, exposure records, raw data, calculations, and deviations.

Device-off decay, untreated controls, blanks, negative controls, and positive controls define baseline loss and endpoint response.

Sampler flow, duct flow, UV meters, timers, environmental probes, and analytical instruments are checked or calibrated before use.

Organism preparation, aerosol load, surface inoculation, recovery, neutralization, and endpoint sensitivity are documented per condition.

Replicate rules, acceptance criteria, calculation methods, exclusion logic, and deviations are retained in the study record.

Chain of custody tracks devices, lamps, organisms, carriers, extracts, raw files, CFD inputs, and final calculations.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
QualityDocumented study records
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

Quick answers to questions UVGI developers, HVAC teams, infection-control stakeholders, and product managers ask when scoping a UV or germicidal ultraviolet study: which setup to use, how organisms and exposure are selected, what drives sample count and timeline, what data is delivered, and where ARE Labs' testing scope ends for certification and approvals by others.

Q.How is the right UVGI test method selected?
A.Begin with the intended claim and installation. Room and upper-room devices typically require chamber bioaerosol studies, duct modules require inline reduction testing, and surface-treatment features require time-kill or carrier work.
Q.Can ARE Labs test upper-room GUV devices?
A.Yes, provided the application can be represented in a controlled chamber or model-supported setup. During protocol development, we define fixture placement, airflow, organism, sampling locations, and exposure limits.
Q.How many devices or samples are needed?
A.Device and replicate counts depend on the lamp configuration, operating modes, organism, surface materials, expected reduction, and whether the study is intended for screening or claim-support documentation.
Q.What drives timeline and scope?
A.The main schedule and cost drivers are fixture complexity, containment needs, organism or surrogate selection, surface recovery, airflow control, UV dose records, replicate structure, and the inclusion of CFD.
Q.Does this testing certify the UVGI device?
A.No. ARE Labs provides defined aerosol, bioaerosol, surface, airflow, and documentation evidence. Electrical safety, ozone certification, radiation safety labeling, and product certification must be addressed by other specialists.

Standards & guidance

Each UVGI disinfection device study is scoped to the standard or guidance framework that fits the device geometry, claim, and endpoint. ISO 17025 serves as the accredited quality-system anchor. ASHRAE, ASTM, EPA, CDC, and NIOSH references provide aligned frameworks when they fit the chamber, duct, surface, organism, exposure, and reporting objective.

QA & Regulatory - Accredited

ISO 17025

Testing-laboratory competence, documented methods, calibration traceability, uncertainty, and data reviewView standard ->Bioaerosol & Indoor Air - Aligned

ASHRAE 241

Infectious aerosol control and equivalent clean airflow context for UVGI room and chamber studiesView standard ->Bioaerosol & Microbial Efficacy - Aligned

ASHRAE 185.1 / ASHRAE 185.2

UV-C air and duct device context for microbial inactivation, airflow, residence time, and sampling plansView standard ->Surface Antimicrobial - Aligned

ASTM E2315 / ASTM E3135

Time-kill and UVGI carrier context for surface exposure, recovery, and microbial reduction studiesView standard ->EPA & Claims - Aligned

EPA FIFRA

Pesticide device claim-support context for truthful, configuration-specific antimicrobial performance evidenceView standard ->Bioaerosol & Indoor Air - Aligned

CDC/NIOSH GUV

Upper-room germicidal ultraviolet placement, exposure-control, and occupied-space guidance contextView standard ->

Related testing services

Test

Bioaerosol Efficacy Testing Room

Core chamber test for room, upper-room, or enclosed UVGI devices where airborne microbial decay is the claim.Read more ->Test

Inline Bioaerosol Reduction

Adds upstream/downstream single-pass evidence for duct UVGI modules and enclosed-flow treatment paths.Read more ->Test

Time-Kill Kinetics

Pairs with UV surface features when exposure time, distance, material, and recovery define the reduction claim.Read more ->Test

Computational Fluid Dynamics (CFD)

Supports UVGI placement, mixing, residence time, shadowing, and sampling-location decisions before or alongside testing.Read more ->